Qui Tam Presentations
Watch Joel Androphy's informative video series, "National Whistleblower Litigation."Watch Now
Joel Androphy and Sarah Frazier served as Program Directors for the American Bar Association’s National False Claims and Qui Tam Trial Institute in 2013 and 2015. Joel and Sarah handled the jury selection, opening argument, and closing argument.
Watch for more information on Joel and Sarah’s workshop in June, 2017 in Washington D.C.
Medical Device Law: Compliance Issues, Best Practice & Trend
Joel Androphy is pleased to be a presenter at the Medical Device Law: Compliance Issues, Best Practice & Trends on October 15-16th, 2015 in Washington D.C . Mr. Androphy will lead a discussion on Regulatory Risk Management and Mitigation. Along with David L. Douglass, John Reed Thomas, Jr., and Jennifer Short, Mr. Androphy will host a practice discussion of approaches to manage, assess and mitigate medical device regulatory risk and associated FCA/qui tam exposure with emphasis on ethical considerations.Click here to learn more
- “National Whistleblower Litigation: Qui Tam, False Claims Act, Dodd-Frank and Tax Cases,” by Joel Androphy. 4 Video Collection. Watch Now.
- “Prosecuting Qui Tam Cases Under the False Claims Act: What it Takes to be Successful,” Law Journal Newsletters and Webinar, November 11, 2008
- “Qui Tam Lawsuits and Whistleblowers,” White Collar Practice for the Business Lawyer and In-House Counsel, South Texas College of Law, July 31, 2008
- “White Collar Crime and Qui Tam Cases,” State Bar of Texas, In House Counsel Course, July 24, 2008
- “White Collar Crime and Qui Tam Cases,” International Association of Defense Counsel, Greenbriar, July 5, 2008
- “White Collar Crime and Qui Tam Cases,” State Bar Annual Meeting, June 27, 2008
- “White Collar Crime and Qui Tam Litigation,” Federal Bar Association, May 15, 2008
- “Off-Label Qui Tam Lawsuits,“ Sixth Annual Off-Label Usage Conference,” Pharmaceutical Education Associates, Chair of the Seminar and Moderator, March 31, 2008
- ”Off-Label Promotion,” Food and Drug Law Institute’s Fifth Annual Enforcement and Litigation Conference, February 5, 2007
- “Off-Label Qui Tam Lawsuits: How to Avoid Them and What to Do if You Get Sued,” Fifth Annual Off-Label Usage Conference, Pharmaceutical Education Associates, Philadelphia, Pennsylvania, September 20 – 21, 2006, (Chair of the Seminar, Moderator, and Speaker on several panels)
- “What Pharmaceutical Companies Need to Know About Preventing and Dealing with Qui Tam Cases: Kickbacks, Off-Label Marketing Violations, and Other Crimes,” Pharmaceutical Education Associates, September 21, 2004, Philadelphia, Pennsylvania
- “White Collar Crime/Qui Tam for Health Care Facilities, Houston Bar Association, Health Care Section, Houston, January 14, 2004
- “Whistleblower and Qui Tam Litigation, Advanced In-House Counsel Course, State Bar of Texas, San Antonio, Texas, August 14, 2003
- “Qui Tam Litigation, Fraud and False Claims, American Health Lawyer’s Association, San Antonio, Texas, July 1, 2003
- “Whistleblower and Qui Tam Litigation: Suing the Corporation for Fraud”, White Collar Crime Conference, State Bar of Texas Annual Meeting, June 13, 2003, Houston, Texas
- “Whistleblower and Qui Tam Litigation: Suing the Corporation for Fraud”, Business Crimes and Civil Responsibility, South Texas College of Law, April 11, 2003, Houston, Texas
- “Qui Tam Litigation,” Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum, November 15, 2002, Philadelphia, Pennsylvania
- Qui Tam Litigation – Suing the Corporation, a Whistleblower’s Jackpot,” White Collar Crime for the Civil Practitioner, State Bar of Texas, November 14 – 15, 2002
This website is designed to provide general information only. This information is not and should not be construed to be legal advice. The transmission of the information found on this website also does not result in the formation of a lawyer-client relationship.
You should be aware that qui tam claims are subject to a Statute of Limitations. The area of limitations periods is complex. There are also first to file rules, public disclosure bars, original source issues, and varying limitations in pursuing retaliation claims. If you wish to pursue your claims, you should promptly seek the opinion of an attorney regarding the merits of your qui tam claim and the applicable statute of limitations.